Physician profile
Sheila Coe Maisel
NPI 1295903896
$3,581.63
in general payments reported to CMS, 2019-2025
16 companies · $2,129 in 2025
The $2,129 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.84 · 2020: $100 · 2021: $296 · 2022: $480 · 2023: $231 · 2024: $282 · 2025: $2,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,406 · Food and Beverage: $1,216 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,406.29 |
| Food and Beverage | $1,216.14 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,092.37 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $380.60 | 2021-2025 | Total30, Precision7 |
| Bausch & Lomb Americas INC. | $345.39 | 2022-2025 | Infuse, Xiidra, Miebo |
| Coopervision INC. | $254.42 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| New World Medical,INC. | $80.24 | 2022 | |
| Glaukos Corporation | $79.97 | 2022-2024 | Radius |
| Visioneering Technologies, INC. | $68.67 | 2020 | |
| Biotissue Holdings INC. | $51.88 | 2025 | |
| Harrow Eye, LLC | $42.93 | 2024 | Vevye |
| Sun Pharmaceutical Industries INC. | $39.63 | 2024-2025 | |
| Abb Con-Cise Optical Group LLC | $35.26 | 2019-2022 | |
| Dompe US, INC. | $31.71 | 2025 | Oxervate |
| Allergan, INC. | $24.35 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Abbvie INC. | $17.56 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $17.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Maisel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.